Ownership history in HighTower Advisors, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which HighTower Advisors, LLC reported a position in APREA THERAPEUTICS INC (APRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 13,864 | — | 0% | 0.00% | $12K | $0.85 |
| 2025 Q3 | UNCHANGED | 13,864 | — | 0% | 0.00% | $20K | $1.48 |
| 2025 Q2 | UNCHANGED | 13,864 | — | 0% | 0.00% | $23K | $1.69 |
| 2025 Q1 | UNCHANGED | 13,864 | — | 0% | 0.00% | $28K | $2.04 |
| 2024 Q4 | UNCHANGED | 13,864 | — | 0% | 0.00% | $46K | $3.29 |
| 2024 Q3 | UNCHANGED | 13,864 | — | 0% | 0.00% | $38K | $2.75 |
| 2024 Q2 | UNCHANGED | 13,864 | — | 0% | 0.00% | $56K | $4.07 |
| 2024 Q1 | INITIATED | 13,864 | — | — | 0.00% | $93K | — |
As of 2025 Q4 — sorted by position size